To avoid failure, launch AI agents with high human control and low agency, such as suggesting actions to an operator. As the agent proves reliable and you collect performance data, you can gradually increase its autonomy. This phased approach minimizes risk and builds user trust.

Unlike general enterprise AI where a wrong answer is an inconvenience, errors in healthcare AI can be fatal. This high-stakes environment forces companies like Abridge to adopt extremely rigorous offline evaluation and phased, progressive rollouts, a far more cautious approach than typical "move fast" software development.

Leaders must resist the temptation to deploy the most powerful AI model simply for a competitive edge. The primary strategic question for any AI initiative should be defining the necessary level of trustworthiness for its specific task and establishing who is accountable if it fails, before deployment begins.

In regulated industries like finance, the primary barrier to full AI automation is often regulation, not just user trust. It is the technology provider's responsibility to prove AI's reliability and safety to regulators, much like the industry did to legitimize e-signatures over a decade ago.

Avoid deploying AI directly into a fully autonomous role for critical applications. Instead, begin with a human-in-the-loop, advisory function. Only after the system has proven its reliability in a real-world environment should its autonomy be gradually increased, moving from supervised to unsupervised operation.

In large enterprises, AI adoption creates a conflict. The CTO pushes for speed and innovation via AI agents, while the CISO worries about security risks from a flood of AI-generated code. Successful devtools must address this duality, providing developer leverage while ensuring security for the CISO.

Treating AI risk management as a final step before launch leads to failure and loss of customer trust. Instead, it must be an integrated, continuous process throughout the entire AI development pipeline, from conception to deployment and iteration, to be effective.

In high-stakes fields like healthcare, the cost of an AI error is immense. Product leaders must prioritize safety, reliability, and the reproducibility of outcomes. A complete audit trail is non-negotiable, as it enables the reversal of incorrect decisions and ensures accountability.

For enterprises, scaling AI content without built-in governance is reckless. Rather than manual policing, guardrails like brand rules, compliance checks, and audit trails must be integrated from the start. The principle is "AI drafts, people approve," ensuring speed without sacrificing safety.